Technical Analysis for BOLD - Audentes Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 59.97 -0.02% -0.01
BOLD closed down 0.02 percent on Tuesday, January 14, 2020, on 1.39 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Extremely Strong Up Up Flat
Historical BOLD trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 1.13%
Pocket Pivot Bullish Swing Setup 1.13%
Volume Surge Other 1.13%
Calm After Storm Range Contraction 1.13%
Narrow Range Bar Range Contraction 1.13%
New 52 Week High Strength 1.13%
Parabolic Rise Strength 1.13%
Wide Bands Range Expansion 1.13%
Above Upper BB Strength 1.13%
Overbought Stochastic Strength 1.13%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Audentes Therapeutics, Inc. is a biotechnology company which focused on developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases. The company's product pipeline consists of AT132 for the treatment of X-linked myotubular myopathy; AT342 for the treatment of crigler-najjar syndrome type 1; AT307 for the treatment of the CASQ2 subtype of catecholaminergic polymorphic ventricular tachycardia and AT982 for the treatment of pompe disease, which are in pre-clinical trial stage. Audentes Therapeutics, Inc. is based in San Francisco, California.
Biotechnology Medical Specialties Organ Systems Rare Diseases Gene Therapy Hepatology Cardiac Arrhythmia Gene Therapy Products Pompe Disease Channelopathies Myopathy Treatment Of Pompe Disease

Is BOLD a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 60.0
52 Week Low 22.0
Average Volume 1,536,887
200-Day Moving Average 37.73
50-Day Moving Average 46.24
20-Day Moving Average 59.78
10-Day Moving Average 59.94
Average True Range 0.51
ADX 80.94
+DI 65.27
-DI 3.97
Chandelier Exit (Long, 3 ATRs ) 58.46
Chandelier Exit (Short, 3 ATRs ) 60.81
Upper Bollinger Band 60.18
Lower Bollinger Band 59.38
Percent B (%b) 0.74
BandWidth 1.35
MACD Line 3.27
MACD Signal Line 4.30
MACD Histogram -1.029
Fundamentals Value
Market Cap 1.67 Billion
Num Shares 27.8 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -17.04
Price-to-Sales 0.00
Price-to-Book 4.35
PEG Ratio -1.48
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 60.00
Resistance 3 (R3) 60.00 60.00 60.00
Resistance 2 (R2) 60.00 59.99 60.00 59.99
Resistance 1 (R1) 59.98 59.98 59.98 59.98 59.99
Pivot Point 59.98 59.98 59.98 59.98 59.98
Support 1 (S1) 59.96 59.97 59.96 59.96 59.95
Support 2 (S2) 59.96 59.96 59.96 59.95
Support 3 (S3) 59.94 59.96 59.95
Support 4 (S4) 59.94